{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T17:02:33Z","timestamp":1775581353332,"version":"3.50.1"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35GM136295"],"award-info":[{"award-number":["R35GM136295"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R01HD118715"],"award-info":[{"award-number":["R01HD118715"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["ZIA-HD001011"],"award-info":[{"award-number":["ZIA-HD001011"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["ZIA-HD008808"],"award-info":[{"award-number":["ZIA-HD008808"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000052","name":"U.S. Department of Health & Human Services | NIH | NIH Office of the Director","doi-asserted-by":"publisher","award":["1S10OD025033"],"award-info":[{"award-number":["1S10OD025033"]}],"id":[{"id":"10.13039\/100000052","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>An interplay of growth factors and signaling pathways governs the development and maintenance of lymphatic vasculature, ensuring proper fluid homeostasis and immune function. Disruption of these regulatory mechanisms can lead to congenital lymphatic disorders and contribute to various pathological conditions. However, the mechanisms underlying the molecular regulation of these processes remain elusive. Here, we reveal a critical and previously unappreciated role for the signaling scaffold protein Shoc2 in lymphangiogenesis. We demonstrate that loss of Shoc2 results in near-complete loss of lymphatic vasculature in vivo and senescence of lymphatic endothelial cells in vitro. Mechanistically, Shoc2 is required for balancing signaling through the ERK1\/2 pathway, and its loss results in increased mTORC1 signaling. This dysregulation impairs mitochondrial respiration and triggers an IRF\/IFN-II response, ultimately leading to cellular senescence. Strikingly, expression of the Noonan Syndrome with Loose anagen Hair (NSLH)-causing Shoc2 variant S2G phenocopies the effects of Shoc2 loss. Together, these studies establish the critical role of Shoc2 in lymphangiogenesis and uncover a novel mechanistic link between Shoc2 signaling, mitochondrial function, innate immune response, and lymphatic development, with significant implications for Ras-pathway-related congenital disorders.<\/jats:p>","DOI":"10.1038\/s41418-026-01730-9","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T14:44:05Z","timestamp":1775573045000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Signaling scaffold Shoc2 regulates lymphangiogenesis by suppressing mTORC1-mediated IFN responses"],"prefix":"10.1038","author":[{"given":"Patricia","family":"Wilson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vishakha","family":"Vishwakarma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Norcross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1465-9469","authenticated-orcid":false,"given":"Kashmira","family":"Khaire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Van N.","family":"Pham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4136-4962","authenticated-orcid":false,"given":"Brant M.","family":"Weinstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8892-0941","authenticated-orcid":false,"given":"Hyun Min","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8743-026X","authenticated-orcid":false,"given":"Emilia","family":"Galperin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"key":"1730_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41392-023-01723-x","volume":"9","author":"Z Hu","year":"2024","unstructured":"Hu Z, Zhao X, Wu Z, Qu B, Yuan M, Xing Y, et al. Lymphatic vessel: origin, heterogeneity, biological functions and therapeutic targets. Signal Transduct Target Ther. 2024;9:9.","journal-title":"Signal Transduct Target Ther"},{"key":"1730_CR2","doi-asserted-by":"crossref","unstructured":"Petrova TV, Koh GY. Biological functions of lymphatic vessels. Science. 2020;369:eaax4063.","DOI":"10.1126\/science.aax4063"},{"key":"1730_CR3","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.molmed.2021.07.003","volume":"27","author":"S Stritt","year":"2021","unstructured":"Stritt S, Koltowska K, Makinen T. Homeostatic maintenance of the lymphatic vasculature. Trends Mol Med. 2021;27:955\u201370.","journal-title":"Trends Mol Med"},{"key":"1730_CR4","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41569-021-00517-4","volume":"18","author":"N Ricard","year":"2021","unstructured":"Ricard N, Bailly S, Guignabert C, Simons M. The quiescent endothelium: signalling pathways regulating organ-specific endothelial normalcy. Nat Rev Cardiol. 2021;18:565\u201380.","journal-title":"Nat Rev Cardiol"},{"key":"1730_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2020.597374","volume":"7","author":"K Bui","year":"2020","unstructured":"Bui K, Hong YK. Ras pathways on prox1 and lymphangiogenesis: insights for therapeutics. Front Cardiovasc Med. 2020;7:597374.","journal-title":"Front Cardiovasc Med"},{"key":"1730_CR6","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1172\/JCI63034","volume":"123","author":"Y Deng","year":"2013","unstructured":"Deng Y, Atri D, Eichmann A, Simons M. Endothelial ERK signaling controls lymphatic fate specification. J Clin Investig. 2013;123:1202\u201315.","journal-title":"J Clin Investig"},{"key":"1730_CR7","doi-asserted-by":"crossref","unstructured":"Zenker M. Clinical overview on RASopathies. Am J Med Genet C Semin Med Genet. 2022;190:414\u201324.","DOI":"10.1002\/ajmg.c.32015"},{"key":"1730_CR8","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.tjog.2024.01.011","volume":"63","author":"CP Chen","year":"2024","unstructured":"Chen CP. Syndromic and single gene disorders associated with fetal pleural effusion (I): Noonan syndrome, RASopathy and congenital lymphatic anomalies. Taiwan J Obstet Gynecol. 2024;63:174\u20137.","journal-title":"Taiwan J Obstet Gynecol"},{"key":"1730_CR9","doi-asserted-by":"crossref","unstructured":"Kleimeier LER, van Schaik C, Leenders E, Itkin M, Klein WM, Draaisma JMT. Lymphatic phenotype of Noonan syndrome: innovative diagnosis and possible implications for therapy. J Clin Med. 2022;11:3128.","DOI":"10.3390\/jcm11113128"},{"key":"1730_CR10","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/ng.425","volume":"41","author":"V Cordeddu","year":"2009","unstructured":"Cordeddu V, Di Schiavi E, Pennacchio LA, Ma\u2019ayan A, Sarkozy A, Fodale V, et al. Mutation of SHOC2 promotes aberrant protein N-myristoylation and causes Noonan-like syndrome with loose anagen hair. Nat Genet. 2009;41:1022\u20136.","journal-title":"Nat Genet"},{"key":"1730_CR11","doi-asserted-by":"crossref","unstructured":"Hannig V, Jeoung M, Jang ER, Phillips JA 3rd, Galperin E. A novel SHOC2 variant in rasopathy. Hum Mutat. 2014;35:1290\u20134.","DOI":"10.1002\/humu.22634"},{"key":"1730_CR12","doi-asserted-by":"publisher","first-page":"3120","DOI":"10.1002\/ajmg.a.36697","volume":"164A","author":"G Baldassarre","year":"2014","unstructured":"Baldassarre G, Mussa A, Banaudi E, Rossi C, Tartaglia M, Silengo M, et al. Phenotypic variability associated with the invariant SHOC2 c.4A>G (p.Ser2Gly) missense mutation. Am J Med Genet A. 2014;164A:3120\u20135.","journal-title":"Am J Med Genet A"},{"key":"1730_CR13","doi-asserted-by":"crossref","unstructured":"Garavelli L, Cordeddu V, Errico S, Bertolini P, Street ME, Rosato S, et al. Noonan syndrome-like disorder with loose anagen hair: a second case with neuroblastoma. Am J Med Genet A. 2015;167A:1902\u20137.","DOI":"10.1002\/ajmg.a.37082"},{"key":"1730_CR14","doi-asserted-by":"crossref","unstructured":"Gargano G, Guidotti I, Balestri E, Vagnarelli F, Rosato S, Comitini G, et al. Hydrops fetalis in a preterm newborn heterozygous for the c.4A>G SHOC2 mutation. Am J Med Genet A. 2014;164A:1015\u201320.","DOI":"10.1002\/ajmg.a.36376"},{"key":"1730_CR15","doi-asserted-by":"crossref","unstructured":"Motta M, Solman M, Bonnard AA, Kuechler A, Pantaleoni F, Priolo M, et al. Expanding the molecular spectrum of pathogenic SHOC2 variants underlying Mazzanti syndrome. Hum Mol Genet. 2022;31:2766\u201378.","DOI":"10.1093\/hmg\/ddac071"},{"key":"1730_CR16","doi-asserted-by":"crossref","unstructured":"Digilio MC, Lepri F, Baban A, Dentici ML, Versacci P, Capolino R, et al. RASopathies: clinical diagnosis in the first year of life. Mol Syndromol. 2011;1:282\u20139.","DOI":"10.1159\/000331266"},{"key":"1730_CR17","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1002\/ajmg.a.36404","volume":"164A","author":"M Zmolikova","year":"2014","unstructured":"Zmolikova M, Puchmajerova A, Hecht P, Lebl J, Trkova M, Krepelova A. Coarctation of the aorta in Noonan-like syndrome with loose anagen hair. Am J Med Genet A. 2014;164A:1218\u201321.","journal-title":"Am J Med Genet A"},{"key":"1730_CR18","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.molcel.2006.03.027","volume":"22","author":"P Rodriguez-Viciana","year":"2006","unstructured":"Rodriguez-Viciana P, Oses-Prieto J, Burlingame A, Fried M, McCormick F. A phosphatase holoenzyme comprised of Shoc2\/Sur8 and the catalytic subunit of PP1 functions as an M-Ras effector to modulate Raf activity. Mol Cell. 2006;22:217\u201330.","journal-title":"Mol Cell"},{"key":"1730_CR19","doi-asserted-by":"crossref","unstructured":"Wilson P, Abdelmoti L, Norcross R, Jang ER, Palayam M, Galperin E. The role of USP7 in the Shoc2-ERK1\/2 signaling axis and Noonan-like syndrome with loose anagen hair. J Cell Sci. 2021;134:jcs258922.","DOI":"10.1242\/jcs.258922"},{"key":"1730_CR20","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1016\/j.celrep.2019.02.052","volume":"26","author":"CM Xie","year":"2019","unstructured":"Xie CM, Tan M, Lin XT, Wu D, Jiang Y, Tan Y, et al. The FBXW7-SHOC2-raptor axis controls the cross-talks between the RAS-ERK and mTORC1 signaling pathways. Cell Rep. 2019;26:3037\u201350.e4.","journal-title":"Cell Rep"},{"key":"1730_CR21","first-page":"4428","volume":"128","author":"ER Jang","year":"2015","unstructured":"Jang ER, Jang H, Shi P, Popa G, Jeoung M, Galperin E. Spatial control of Shoc2-scaffold-mediated ERK1\/2 signaling requires remodeling activity of the ATPase PSMC5. J Cell Sci. 2015;128:4428\u201341.","journal-title":"J Cell Sci"},{"key":"1730_CR22","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1091\/mbc.E19-03-0144","volume":"30","author":"H Jang","year":"2019","unstructured":"Jang H, Jang ER, Wilson PG, Anderson D, Galperin E. VCP\/p97 controls signals of the ERK1\/2 pathway transmitted via the Shoc2 scaffolding complex: novel insights into IBMPFD pathology. Mol Biol Cell. 2019;30:1655\u201363.","journal-title":"Mol Biol Cell"},{"key":"1730_CR23","doi-asserted-by":"publisher","first-page":"e1188241","DOI":"10.1080\/19420889.2016.1188241","volume":"9","author":"ER Jang","year":"2016","unstructured":"Jang ER, Galperin E. The function of Shoc2: a scaffold and beyond. Commun Integr Biol. 2016;9:e1188241.","journal-title":"Commun Integr Biol"},{"key":"1730_CR24","doi-asserted-by":"crossref","unstructured":"Kaduwal S, Jeong WJ, Park JC, Lee KH, Lee YM, Jeon SH, et al. Sur8\/Shoc2 promotes cell motility and metastasis through activation of Ras-PI3K signaling. Oncotarget. 2015;6:33091\u2013105.","DOI":"10.18632\/oncotarget.5173"},{"key":"1730_CR25","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1093\/hmg\/ddy366","volume":"28","author":"H Jang","year":"2019","unstructured":"Jang H, Oakley E, Forbes-Osborne M, Kesler MV, Norcross R, Morris AC, et al. Hematopoietic and neural crest defects in zebrafish shoc2 mutants: a novel vertebrate model for Noonan-like syndrome. Hum Mol Genet. 2019;28:501\u201314.","journal-title":"Hum Mol Genet"},{"key":"1730_CR26","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1002\/dvdy.22343","volume":"239","author":"J Yi","year":"2010","unstructured":"Yi J, Chen M, Wu X, Yang X, Xu T, Zhuang Y, et al. Endothelial SUR-8 acts in an ERK-independent pathway during atrioventricular cushion development. Dev Dyn. 2010;239:2005\u201313.","journal-title":"Dev Dyn"},{"key":"1730_CR27","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/9780470319413.ch11","volume":"283","author":"K Yaniv","year":"2007","unstructured":"Yaniv K, Isogai S, Castranova D, Dye L, Hitomi J, Weinstein BM. Imaging the developing lymphatic system using the zebrafish. Novartis Found Symp. 2007;283:139\u201348.","journal-title":"Novartis Found Symp"},{"key":"1730_CR28","first-page":"2070","volume":"144","author":"HM Jung","year":"2017","unstructured":"Jung HM, Castranova D, Swift MR, Pham VN, Venero Galanternik M, Isogai S, et al. Development of the larval lymphatic system in zebrafish. Development. 2017;144:2070\u201381.","journal-title":"Development"},{"key":"1730_CR29","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/nm1427","volume":"12","author":"K Yaniv","year":"2006","unstructured":"Yaniv K, Isogai S, Castranova D, Dye L, Hitomi J, Weinstein BM. Live imaging of lymphatic development in the zebrafish. Nat Med. 2006;12:711\u20136.","journal-title":"Nat Med"},{"key":"1730_CR30","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.devcel.2012.01.011","volume":"22","author":"YR Cha","year":"2012","unstructured":"Cha YR, Fujita M, Butler M, Isogai S, Kochhan E, Siekmann AF, et al. Chemokine signaling directs trunk lymphatic network formation along the preexisting blood vasculature. Dev Cell. 2012;22:824\u201336.","journal-title":"Dev Cell"},{"key":"1730_CR31","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nri3344","volume":"13","author":"MS Diamond","year":"2013","unstructured":"Diamond MS, Farzan M. The broad-spectrum antiviral functions of IFIT and IFITM proteins. Nat Rev Immunol. 2013;13:46\u201357.","journal-title":"Nat Rev Immunol"},{"key":"1730_CR32","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1038\/s12276-022-00872-3","volume":"54","author":"JA Kang","year":"2022","unstructured":"Kang JA, Kim YJ, Jeon YJ. The diverse repertoire of ISG15: more intricate than initially thought. Exp Mol Med. 2022;54:1779\u201392.","journal-title":"Exp Mol Med"},{"key":"1730_CR33","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/j.1432-1033.1994.tb18636.x","volume":"220","author":"HA Bluyssen","year":"1994","unstructured":"Bluyssen HA, Vlietstra RJ, van der Made A, Trapman J. The interferon-stimulated gene 54 K promoter contains two adjacent functional interferon-stimulated response elements of different strength, which act synergistically for maximal interferon-alpha inducibility. Eur J Biochem. 1994;220:395\u2013402.","journal-title":"Eur J Biochem"},{"key":"1730_CR34","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1089\/jir.1998.18.773","volume":"18","author":"T Ronni","year":"1998","unstructured":"Ronni T, Matikainen S, Lehtonen A, Palvimo J, Dellis J, Van Eylen F, et al. The proximal interferon-stimulated response elements are essential for interferon responsiveness: a promoter analysis of the antiviral MxA gene. J Interferon Cytokine Res. 1998;18:773\u201381.","journal-title":"J Interferon Cytokine Res"},{"key":"1730_CR35","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1006\/bbrc.1999.0683","volume":"258","author":"T Ohtomo","year":"1999","unstructured":"Ohtomo T, Sugamata Y, Ozaki Y, Ono K, Yoshimura Y, Kawai S, et al. Molecular cloning and characterization of a surface antigen preferentially overexpressed on multiple myeloma cells. Biochem Biophys Res Commun. 1999;258:583\u201391.","journal-title":"Biochem Biophys Res Commun"},{"key":"1730_CR36","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nri1604","volume":"5","author":"LC Platanias","year":"2005","unstructured":"Platanias LC. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol. 2005;5:375\u201386.","journal-title":"Nat Rev Immunol"},{"key":"1730_CR37","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12929-014-0110-2","volume":"22","author":"CY Ko","year":"2015","unstructured":"Ko CY, Chang WC, Wang JM. Biological roles of CCAAT\/Enhancer-binding protein delta during inflammation. J Biomed Sci. 2015;22:6.","journal-title":"J Biomed Sci"},{"key":"1730_CR38","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1074\/jbc.M004885200","volume":"276","author":"J Hu","year":"2001","unstructured":"Hu J, Roy SK, Shapiro PS, Rodig SR, Reddy SP, Platanias LC, et al. ERK1 and ERK2 activate CCAAAT\/enhancer-binding protein-beta-dependent gene transcription in response to interferon-gamma. J Biol Chem. 2001;276:287\u201397.","journal-title":"J Biol Chem"},{"key":"1730_CR39","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.immuni.2012.11.018","volume":"38","author":"E Wies","year":"2013","unstructured":"Wies E, Wang MK, Maharaj NP, Chen K, Zhou S, Finberg RW, et al. Dephosphorylation of the RNA sensors RIG-I and MDA5 by the phosphatase PP1 is essential for innate immune signaling. Immunity. 2013;38:437\u201349.","journal-title":"Immunity"},{"key":"1730_CR40","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3389\/fimmu.2014.00342","volume":"5","author":"S Reikine","year":"2014","unstructured":"Reikine S, Nguyen JB, Modis Y. Pattern recognition and signaling mechanisms of RIG-I and MDA5. Front Immunol. 2014;5:342.","journal-title":"Front Immunol"},{"key":"1730_CR41","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/s41564-021-00884-1","volume":"6","author":"G Liu","year":"2021","unstructured":"Liu G, Lee JH, Parker ZM, Acharya D, Chiang JJ, van Gent M, et al. ISG15-dependent activation of the sensor MDA5 is antagonized by the SARS-CoV-2 papain-like protease to evade host innate immunity. Nat Microbiol. 2021;6:467\u201378.","journal-title":"Nat Microbiol"},{"key":"1730_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/celldisc.2016.24","volume":"2","author":"X Sun","year":"2016","unstructured":"Sun X, Sun L, Zhao Y, Li Y, Lin W, Chen D, et al. MAVS maintains mitochondrial homeostasis via autophagy. Cell Discov. 2016;2:16024.","journal-title":"Cell Discov"},{"key":"1730_CR43","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s44324-024-00008-3","volume":"2","author":"E Marques","year":"2024","unstructured":"Marques E, Kramer R, Ryan DG. Multifaceted mitochondria in innate immunity. NPJ Metab Health Dis. 2024;2:6.","journal-title":"NPJ Metab Health Dis"},{"key":"1730_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51363-0","volume":"15","author":"V Lopez-Polo","year":"2024","unstructured":"Lopez-Polo V, Maus M, Zacharioudakis E, Lafarga M, Attolini CS, Marques FDM, et al. Release of mitochondrial dsRNA into the cytosol is a key driver of the inflammatory phenotype of senescent cells. Nat Commun. 2024;15:7378.","journal-title":"Nat Commun"},{"key":"1730_CR45","doi-asserted-by":"crossref","unstructured":"Xie CM, Sun Y. The MTORC1-mediated autophagy is regulated by the FBXW7-SHOC2-RPTOR axis. Autophagy. 2019;15:1470\u201372.","DOI":"10.1080\/15548627.2019.1609864"},{"key":"1730_CR46","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1172\/JCI89607","volume":"127","author":"PE Lapinski","year":"2017","unstructured":"Lapinski PE, Lubeck BA, Chen D, Doosti A, Zawieja SD, Davis MJ, et al. RASA1 regulates the function of lymphatic vessel valves in mice. J Clin Investig. 2017;127:2569\u201385.","journal-title":"J Clin Investig"},{"key":"1730_CR47","doi-asserted-by":"crossref","unstructured":"Norcross RG, Abdelmoti L, Rouchka EC, Andreeva K, Tussey O, Landestoy D, et al. Shoc2 controls ERK1\/2-driven neural crest development by balancing components of the extracellular matrix. Dev Biol. 2022;492:156\u201371.","DOI":"10.1016\/j.ydbio.2022.10.010"},{"key":"1730_CR48","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1146\/annurev-cancerbio-062822-030450","volume":"8","author":"DA Bonsor","year":"2024","unstructured":"Bonsor DA, Simanshu DK. RAS and SHOC2 roles in RAF activation and therapeutic considerations. Annu Rev Cancer Biol. 2024;8:97\u2013113.","journal-title":"Annu Rev Cancer Biol"},{"key":"1730_CR49","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1158\/1541-7786.MCR-20-0664","volume":"19","author":"H Terai","year":"2021","unstructured":"Terai H, Hamamoto J, Emoto K, Masuda T, Manabe T, Kuronuma S, et al. SHOC2 is a critical modulator of sensitivity to EGFR-TKIs in non-small cell lung cancer cells. Mol Cancer Res. 2021;19:317\u201328.","journal-title":"Mol Cancer Res"},{"key":"1730_CR50","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.celrep.2019.08.090","volume":"29","author":"R Sulahian","year":"2019","unstructured":"Sulahian R, Kwon JJ, Walsh KH, Pailler E, Bosse TL, Thaker M, et al. Synthetic lethal interaction of SHOC2 depletion with MEK inhibition in RAS-driven cancers. Cell Rep. 2019;29:118\u201334.e8.","journal-title":"Cell Rep"},{"key":"1730_CR51","doi-asserted-by":"crossref","unstructured":"You X, Dou L, Tan M, Xiong X, Sun Y. SHOC2 plays an oncogenic or tumor-suppressive role by differentially targeting the MAPK and mTORC1 signals in liver cancer. Life Med. 2024;3:lnae23.","DOI":"10.1093\/lifemedi\/lnae023"},{"key":"1730_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16312-7","volume":"11","author":"B Yu","year":"2020","unstructured":"Yu B, Ma J, Li J, Wang D, Wang Z, Wang S. Mitochondrial phosphatase PGAM5 modulates cellular senescence by regulating mitochondrial dynamics. Nat Commun. 2020;11:2549.","journal-title":"Nat Commun"},{"key":"1730_CR53","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41392-023-01547-9","volume":"8","author":"W Chen","year":"2023","unstructured":"Chen W, Zhao H, Li Y. Mitochondrial dynamics in health and disease: mechanisms and potential targets. Signal Transduct Target Ther. 2023;8:333.","journal-title":"Signal Transduct Target Ther"},{"key":"1730_CR54","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1083\/jcb.201610113","volume":"216","author":"B Carroll","year":"2017","unstructured":"Carroll B, Nelson G, Rabanal-Ruiz Y, Kucheryavenko O, Dunhill-Turner NA, Chesterman CC, et al. Persistent mTORC1 signaling in cell senescence results from defects in amino acid and growth factor sensing. J Cell Biol. 2017;216:1949\u201357.","journal-title":"J Cell Biol"},{"key":"1730_CR55","doi-asserted-by":"crossref","unstructured":"de la Cruz L\u00f3pez KG, Toledo Guzm\u00e1n ME, S\u00e1nchez EO, Garc\u00eda Carranc\u00e1 A. mTORC1 as a regulator of mitochondrial functions and a therapeutic target in cancer. Front Oncol. 2019;9:1373.","DOI":"10.3389\/fonc.2019.01373"},{"key":"1730_CR56","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.molcel.2017.08.013","volume":"67","author":"M Morita","year":"2017","unstructured":"Morita M, Prudent J, Basu K, Goyon V, Katsumura S, Hulea L, et al. mTOR controls mitochondrial dynamics and cell survival via MTFP1. Mol Cell. 2017;67:922\u201335.e5.","journal-title":"Mol Cell"},{"key":"1730_CR57","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1038\/s12276-023-01121-x","volume":"55","author":"J Yoon","year":"2023","unstructured":"Yoon J, Kim S, Lee M, Kim Y. Mitochondrial nucleic acids in innate immunity and beyond. Exp Mol Med. 2023;55:2508\u201318.","journal-title":"Exp Mol Med"},{"key":"1730_CR58","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1089\/jir.2006.26.568","volume":"26","author":"X Shao","year":"2006","unstructured":"Shao X, Liu C. Influence of IFN- alpha and IFN- gamma on lymphangiogenesis. J Interferon Cytokine Res. 2006;26:568\u201374.","journal-title":"J Interferon Cytokine Res"},{"key":"1730_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.937982","volume":"10","author":"SS Kemp","year":"2022","unstructured":"Kemp SS, Penn MR, Koller GM, Griffin CT, Davis GE. Proinflammatory mediators, TNFalpha, IFNgamma, and thrombin, directly induce lymphatic capillary tube regression. Front Cell Dev Biol. 2022;10:937982.","journal-title":"Front Cell Dev Biol"},{"key":"1730_CR60","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3389\/fimmu.2019.00036","volume":"10","author":"ED Lucas","year":"2019","unstructured":"Lucas ED, Tamburini BAJ. Lymph node lymphatic endothelial cell expansion and contraction, and the programming of the immune response. Front Immunol. 2019;10:36.","journal-title":"Front Immunol"},{"key":"1730_CR61","doi-asserted-by":"publisher","first-page":"e1012010","DOI":"10.1371\/journal.ppat.1012010","volume":"20","author":"A Embry","year":"2024","unstructured":"Embry A, Baggett NS, Heisler DB, White A, de Jong MF, Kocsis BL, et al. Exploiting bacterial effector proteins to uncover evolutionarily conserved antiviral host machinery. PLoS Pathog. 2024;20:e1012010.","journal-title":"PLoS Pathog"},{"key":"1730_CR62","doi-asserted-by":"publisher","first-page":"e1010253","DOI":"10.1371\/journal.ppat.1010253","volume":"18","author":"BR Zhao","year":"2022","unstructured":"Zhao BR, Wang XX, Wang XW. Shoc2 recognizes bacterial flagellin and mediates antibacterial Erk\/Stat signaling in an invertebrate. PLoS Pathog. 2022;18:e1010253.","journal-title":"PLoS Pathog"},{"key":"1730_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2019.100842","volume":"71","author":"L Dard","year":"2020","unstructured":"Dard L, Blanchard W, Hubert C, Lacombe D, Rossignol R. Mitochondrial functions and rare diseases. Mol Asp Med. 2020;71:100842.","journal-title":"Mol Asp Med"},{"key":"1730_CR64","doi-asserted-by":"crossref","unstructured":"Dard L, Hubert C, Esteves P, Blanchard W, Bou About G, Baldasseroni L, et al. HRAS germline mutations impair LKB1\/AMPK signaling and mitochondrial homeostasis in Costello syndrome models. J Clin Investig. 2022;132:e131053.","DOI":"10.1172\/JCI131053"},{"key":"1730_CR65","doi-asserted-by":"crossref","unstructured":"Bajia D, Bottani E, Derwich K. Effects of Noonan syndrome-germline mutations on mitochondria and energy metabolism. Cells. 2022;11:3099.","DOI":"10.3390\/cells11193099"},{"key":"1730_CR66","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.bbadis.2009.10.005","volume":"1802","author":"I Lee","year":"2010","unstructured":"Lee I, Pecinova A, Pecina P, Neel BG, Araki T, Kucherlapati R, et al. A suggested role for mitochondria in Noonan syndrome. Biochim Biophys Acta. 2010;1802:275\u201383.","journal-title":"Biochim Biophys Acta"},{"key":"1730_CR67","doi-asserted-by":"publisher","first-page":"16064","DOI":"10.1073\/pnas.0405041101","volume":"101","author":"EE Zhang","year":"2004","unstructured":"Zhang EE, Chapeau E, Hagihara K, Feng GS. Neuronal Shp2 tyrosine phosphatase controls energy balance and metabolism. Proc Natl Acad Sci USA. 2004;101:16064\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1730_CR68","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/ejhg.2010.171","volume":"19","author":"T Kleefstra","year":"2011","unstructured":"Kleefstra T, Wortmann SB, Rodenburg RJ, Bongers EM, Hadzsiev K, Noordam C, et al. Mitochondrial dysfunction and organic aciduria in five patients carrying mutations in the Ras-MAPK pathway. Eur J Hum Genet. 2011;19:138\u201344.","journal-title":"Eur J Hum Genet"},{"key":"1730_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2023.103462","volume":"22","author":"D Rigante","year":"2023","unstructured":"Rigante D, Leoni C, Onesimo R, Giorgio V, Trevisan V, Zampino G. Aberrant N-myristoylation as a prelude to autoimmune manifestations in patients with SHOC2 mutations. Autoimmun Rev. 2023;22:103462.","journal-title":"Autoimmun Rev"},{"key":"1730_CR70","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1002\/ajmg.a.35290","volume":"158A","author":"CR Quaio","year":"2012","unstructured":"Quaio CR, Carvalho JF, da Silva CA, Bueno C, Brasil AS, Pereira AC, et al. Autoimmune disease and multiple autoantibodies in 42 patients with RASopathies. Am J Med Genet A. 2012;158A:1077\u201382.","journal-title":"Am J Med Genet A"},{"key":"1730_CR71","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-021-02050-6","volume":"16","author":"MA Siano","year":"2021","unstructured":"Siano MA, Marchetti V, Pagano S, Di Candia F, Alessio M, De Brasi D, et al. Risk of autoimmune diseases in patients with RASopathies: systematic study of humoral and cellular immunity. Orphanet J Rare Dis. 2021;16:410.","journal-title":"Orphanet J Rare Dis"},{"key":"1730_CR72","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.semarthrit.2013.04.009","volume":"43","author":"B Bader-Meunier","year":"2013","unstructured":"Bader-Meunier B, Cave H, Jeremiah N, Magerus A, Lanzarotti N, Rieux-Laucat F, et al. Are RASopathies new monogenic predisposing conditions to the development of systemic lupus erythematosus? Case report and systematic review of the literature. Semin Arthritis Rheum. 2013;43:217\u20139.","journal-title":"Semin Arthritis Rheum"},{"key":"1730_CR73","first-page":"405","volume":"63","author":"XO Wang","year":"2025","unstructured":"Wang XO, Liu ZQ, Shangguan SF, Lai JM, Wang PC, Song FY, et al. [Clinical characteristics analysis of children with Noonan-like syndrome with loose anagen hair]. Zhonghua Er Ke Za Zhi. 2025;63:405\u201310.","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"1730_CR74","doi-asserted-by":"crossref","unstructured":"Menento\u011flu B, Konur Akba\u015f EN, Kavrul Kayaalp G, Akg\u00fcn \u00d6, Aslanger AD, Uyguner ZO, et al. Complex crosstalk: early-onset lupus and antiphospholipid syndrome in a child with SHOC2-related RASopathy. Rheumatology. 2025;64:4852\u20133.","DOI":"10.1093\/rheumatology\/keaf144"},{"key":"1730_CR75","doi-asserted-by":"publisher","first-page":"159","DOI":"10.33160\/yam.2019.03.022","volume":"62","author":"T Okazaki","year":"2019","unstructured":"Okazaki T, Saito Y, Sugita K, Nosaka K, Ohno K, Hiraoka Y, et al. Recurrent erythema nodosum in a child with a SHOC2 gene mutation. Yonago acta Med. 2019;62:159\u201362.","journal-title":"Yonago acta Med"},{"key":"1730_CR76","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/B978-0-12-397926-1.00003-2","volume":"534","author":"M Jeoung","year":"2014","unstructured":"Jeoung M, Galperin E. Visualizing of signaling proteins on endosomes utilizing a knockdown and reconstitution approach. Methods Enzym. 2014;534:47\u201363.","journal-title":"Methods Enzym"},{"key":"1730_CR77","doi-asserted-by":"crossref","unstructured":"Kim DH, Sarbassov DD, Ali SM, King JE, Latek RR, Erdjument-Bromage H, et al. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell. 2002;110:163\u201375.","DOI":"10.1016\/S0092-8674(02)00808-5"},{"key":"1730_CR78","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/aja.1002030302","volume":"203","author":"CB Kimmel","year":"1995","unstructured":"Kimmel CB, Ballard WW, Kimmel SR, Ullmann B, Schilling TF. Stages of embryonic development of the zebrafish. Dev Dyn. 1995;203:253\u2013310.","journal-title":"Dev Dyn"},{"key":"1730_CR79","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1242\/dev.058776","volume":"138","author":"M Fujita","year":"2011","unstructured":"Fujita M, Cha YR, Pham VN, Sakurai A, Roman BL, Gutkind JS, et al. Assembly and patterning of the vascular network of the vertebrate hindbrain. Development. 2011;138:1705\u201315.","journal-title":"Development"},{"key":"1730_CR80","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1006\/dbio.2002.0711","volume":"248","author":"ND Lawson","year":"2002","unstructured":"Lawson ND, Weinstein BM. In vivo imaging of embryonic vascular development using transgenic zebrafish. Dev Biol. 2002;248:307\u201318.","journal-title":"Dev Biol"},{"key":"1730_CR81","doi-asserted-by":"publisher","first-page":"3088","DOI":"10.1002\/dvdy.21343","volume":"236","author":"KM Kwan","year":"2007","unstructured":"Kwan KM, Fujimoto E, Grabher C, Mangum BD, Hardy ME, Campbell DS, et al. The Tol2kit: a multisite gateway-based construction kit for Tol2 transposon transgenesis constructs. Dev Dyn. 2007;236:3088\u201399.","journal-title":"Dev Dyn"}],"container-title":["Cell Death &amp; Differentiation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01730-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01730-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01730-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T16:02:24Z","timestamp":1775577744000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01730-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":81,"alternative-id":["1730"],"URL":"https:\/\/doi.org\/10.1038\/s41418-026-01730-9","relation":{},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,7]]},"assertion":[{"value":"14 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods detailed in this study were performed in accordance with the relevant guidelines and regulations. This study only involved live vertebrates, and no human participants were involved. For the component of this study involving live vertebrates the ethics approval was obtained from the University of Kentucky Animal Care and Use Committee (#2019-3208), the University of Illinois at Chicago Animal Care and Use Committee (#23-112), and the\n                      Eunice Kennedy Shriver\n                      National Institute of Child Health and Human Development Committee (Animal Study Proposal #21-015, 24-015).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}